Literature DB >> 19196675

The burden of respiratory syncytial virus infection in young children.

Caroline Breese Hall1, Geoffrey A Weinberg, Marika K Iwane, Aaron K Blumkin, Kathryn M Edwards, Mary A Staat, Peggy Auinger, Marie R Griffin, Katherine A Poehling, Dean Erdman, Carlos G Grijalva, Yuwei Zhu, Peter Szilagyi.   

Abstract

BACKGROUND: The primary role of respiratory syncytial virus (RSV) in causing infant hospitalizations is well recognized, but the total burden of RSV infection among young children remains poorly defined.
METHODS: We conducted prospective, population-based surveillance of acute respiratory infections among children under 5 years of age in three U.S. counties. We enrolled hospitalized children from 2000 through 2004 and children presenting as outpatients in emergency departments and pediatric offices from 2002 through 2004. RSV was detected by culture and reverse-transcriptase polymerase chain reaction. Clinical information was obtained from parents and medical records. We calculated population-based rates of hospitalization associated with RSV infection and estimated the rates of RSV-associated outpatient visits.
RESULTS: Among 5067 children enrolled in the study, 919 (18%) had RSV infections. Overall, RSV was associated with 20% of hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. Average annual hospitalization rates were 17 per 1000 children under 6 months of age and 3 per 1000 children under 5 years of age. Most of the children had no coexisting illnesses. Only prematurity and a young age were independent risk factors for hospitalization. Estimated rates of RSV-associated office visits among children under 5 years of age were three times those in emergency departments. Outpatients had moderately severe RSV-associated illness, but few of the illnesses (3%) were diagnosed as being caused by RSV.
CONCLUSIONS: RSV infection is associated with substantial morbidity in U.S. children in both inpatient and outpatient settings. Most children with RSV infection were previously healthy, suggesting that control strategies targeting only high-risk children will have a limited effect on the total disease burden of RSV infection. 2009 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2009        PMID: 19196675      PMCID: PMC4829966          DOI: 10.1056/NEJMoa0804877

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 2.  Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease.

Authors:  Eric A F Simoes
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

Review 3.  New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.

Authors:  Peter L Collins; Brian R Murphy
Journal:  Proc Am Thorac Soc       Date:  2005

4.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

5.  Influenza burden for children with asthma.

Authors:  E Kathryn Miller; Marie R Griffin; Kathryn M Edwards; Geoffrey A Weinberg; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Yuwei Zhu; Caroline B Hall; Gerry Fairbrother; Ranee Seither; Dean Erdman; Pengjun Lu; Katherine A Poehling
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

6.  The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Authors:  Barbara J Law; Joanne M Langley; Upton Allen; Bosco Paes; David S C Lee; Ian Mitchell; John Sampalis; Hervé Walti; Joan Robinson; Karel O'Brien; Carina Majaesic; Georges Caouette; Lyne Frenette; Nicole Le Saux; Brian Simmons; Sharon Moisiuk; Koravanagattu Sankaran; Cecil Ojah; Avash J Singh; Marc H Lebel; Godfrey S Bacheyie; Heather Onyett; Andrea Michaliszyn; Patricia Manzi; Diana Parison
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

7.  GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness.

Authors:  Dean D Erdman; Geoffrey A Weinberg; Kathryn M Edwards; Frances J Walker; Barbara C Anderson; Jörn Winter; Monica González; Larry J Anderson
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

8.  Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.

Authors:  Giovanni A Rossi; Maria Cristina Medici; Maria Cristina Arcangeletti; Marcello Lanari; Rocco Merolla; Umberto Di Luzio Paparatti; Michela Silvestri; Angela Pistorio; Carlo Chezzi
Journal:  Eur J Pediatr       Date:  2007-02-17       Impact factor: 3.183

9.  Rhinovirus-associated hospitalizations in young children.

Authors:  E Kathryn Miller; Xiaoyan Lu; Dean D Erdman; Katherine A Poehling; Yuwei Zhu; Marie R Griffin; Tina V Hartert; Larry J Anderson; Geoffrey A Weinberg; Caroline B Hall; Marika K Iwane; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2007-02-02       Impact factor: 5.226

10.  A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life.

Authors:  Marie-Louise von Linstow; Mette Høgh; Svein Arne Nordbø; Jesper Eugen-Olsen; Anders Koch; Birthe Høgh
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

View more
  780 in total

1.  Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.

Authors:  Jessica W Lau; Young-In Kim; Ryan Murphy; Ruchi Newman; Xiao Yang; Michael Zody; John DeVincenzo; Yonatan H Grad
Journal:  Virology       Date:  2017-08-03       Impact factor: 3.616

2.  Respiratory syncytial virus infection in human bone marrow stromal cells.

Authors:  Fariba Rezaee; Laura F Gibson; Debbie Piktel; Sreekumar Othumpangat; Giovanni Piedimonte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

3.  What happens when you mix a transplant with respiratory syncytial virus?

Authors:  Joan L Robinson; Danielle Grenier
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

4.  Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.

Authors:  Gertrud U Radu; Hayat Caidi; Congrong Miao; Ralph A Tripp; Larry J Anderson; Lia M Haynes
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

6.  The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion.

Authors:  Imogen M Bermingham; Keith J Chappell; Daniel Watterson; Paul R Young
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

7.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults.

Authors:  Edward E Walsh; Derick R Peterson; Aja E Kalkanoglu; Frances Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

8.  Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells.

Authors:  Jens Loebbermann; Lydia Durant; Hannah Thornton; Cecilia Johansson; Peter J Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs.

Authors:  Amy G Feldman; Brenda L Beaty; Donna Curtis; Elizabeth Juarez-Colunga; Allison Kempe
Journal:  JAMA Pediatr       Date:  2019-03-01       Impact factor: 16.193

10.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.